View in EDS HTML Full Text PDF Full Text

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Saved in:
Bibliographic Details
Title: Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576
Authors: Castro, Januario E.1,2 (AUTHOR), Lengerke-Diaz, Paula A.1 (AUTHOR), Velez Lujan, Juliana2 (AUTHOR), Choi, Michael Y.2,3 (AUTHOR), Moreno-Cortes, Eider F.1 (AUTHOR), Forero, Jose V.1 (AUTHOR), Garcia-Robledo, Juan Esteban1 (AUTHOR), Jacobs, Chaja3 (AUTHOR), McCarthy, Colin3 (AUTHOR), Heinen, Alaina3 (AUTHOR), Amaya-Chanaga, Carlos I.4 (AUTHOR), Kipps, Thomas J.2,3 (AUTHOR)
Source: Advances in Hematology. 1/22/2022, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 154823174
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Castro%2C+Januario+E%2E%22">Castro, Januario E.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lengerke-Diaz%2C+Paula+A%2E%22">Lengerke-Diaz, Paula A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Velez+Lujan%2C+Juliana%22">Velez Lujan, Juliana</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choi%2C+Michael+Y%2E%22">Choi, Michael Y.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreno-Cortes%2C+Eider+F%2E%22">Moreno-Cortes, Eider F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Forero%2C+Jose+V%2E%22">Forero, Jose V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garcia-Robledo%2C+Juan+Esteban%22">Garcia-Robledo, Juan Esteban</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jacobs%2C+Chaja%22">Jacobs, Chaja</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McCarthy%2C+Colin%22">McCarthy, Colin</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heinen%2C+Alaina%22">Heinen, Alaina</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amaya-Chanaga%2C+Carlos+I%2E%22">Amaya-Chanaga, Carlos I.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kipps%2C+Thomas+J%2E%22">Kipps, Thomas J.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Advances+in+Hematology%22">Advances in Hematology</searchLink>. 1/22/2022, p1-8. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=154823174
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1155/2022/4450824
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1
    Titles:
      – TitleFull: Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Castro, Januario E.
      – PersonEntity:
          Name:
            NameFull: Lengerke-Diaz, Paula A.
      – PersonEntity:
          Name:
            NameFull: Velez Lujan, Juliana
      – PersonEntity:
          Name:
            NameFull: Choi, Michael Y.
      – PersonEntity:
          Name:
            NameFull: Moreno-Cortes, Eider F.
      – PersonEntity:
          Name:
            NameFull: Forero, Jose V.
      – PersonEntity:
          Name:
            NameFull: Garcia-Robledo, Juan Esteban
      – PersonEntity:
          Name:
            NameFull: Jacobs, Chaja
      – PersonEntity:
          Name:
            NameFull: McCarthy, Colin
      – PersonEntity:
          Name:
            NameFull: Heinen, Alaina
      – PersonEntity:
          Name:
            NameFull: Amaya-Chanaga, Carlos I.
      – PersonEntity:
          Name:
            NameFull: Kipps, Thomas J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 01
              Text: 1/22/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 16879104
          Titles:
            – TitleFull: Advances in Hematology
              Type: main
ResultId 1